XML 154 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT REPORTING PROFIT AND LOSS

Information related to the operations of the Company’s reportable operating segments is set forth below:

 

   Pathogen prevention   Global warming solutions    Total 
Year ended December 31, 2023                
Revenues   263,445    -     263,445 
Operating loss   (1,098,383)   (1,788,093)    (2,886,476)
Unallocated amounts:                
Unallocated costs              

(4,691,300

)
Total operating loss              

(7,577,776

)
Financing income, net              46,511 
Other income              984,940 
Changes in fair value of an investment in an associate measured under the fair value option              (713,593)
Net loss              (7,259,918)
SCHEDULE OF INFORMATION ON SALES BY GEOGRAPHIC DISTRIBUTION

Sales are attributed to geographic distribution based on the location of the customer.

  

   2023   2022 
   Year ended December 31 
   2023   2022 
         
United States   142,733    163,644 
Mexico   109,824    154,425 
Israel   9,869    29,998 
Turkey   1,019    45,937 
 Revenues from sales of products   263,445    394,004 
SCHEDULE OF SALES TO CUSTOMERS

   2023   2022 
   Year ended December 31 
   2023   2022 
         
Customer A   142,733    163,644 
Customer B   109,824    154,425 
Customer C   -    45,937 
 Revenues from sales of products   252,557    364,006 
SCHEDULE OF INFORMATION ON LONG LIVED ASSETS

The following table presents the locations of the Company’s long-lived assets as of December 31, 2023 and 2022:

 

   2023   2022 
   Year ended December 31 
   2023   2022 
         
Israel   102,103    207,779 
United States   21,046    11,990 
Property, plant and equipment and ROU assets   123,149    219,769